🔎 Trials Near Me

Pradžia › Berkito limfoma › Ilinoisas › Chicago

Berkito limfoma klinikiniai tyrimai Chicago, IL

14 tyrimai dėl Berkito limfoma ieško dalyvių vietose Chicago ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Renkami dalyviai2 fazė
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
366 Days – 46 Years · Visoms lytims · Atnaujinta 2026-10-02 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Renkami dalyviai3 fazė
  • Northwestern University, Chicago
  • Rush MD Anderson Cancer Center, Chicago
  • University of Illinois, Chicago
  • ir dar 1
Amžius nuo 18 iki 39 · Visoms lytims · Atnaujinta 2026-10-02 · NCT03150693

Blinatumomab Consolidation in Real World

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
  • Northwestern University, Chicago
  • The University of Chicago, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07117136

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Renkami dalyviai2 fazė
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-29 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Renkami dalyviai2 fazė
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
365 Days · Visoms lytims · Atnaujinta 2026-09-25 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Renkami dalyviai2 fazė
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
Amžius nuo 1 iki 30 · Visoms lytims · Atnaujinta 2026-09-01 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Renkami dalyviai3 fazė
  • Lurie Children's Hospital-Chicago, Chicago
  • University of Illinois, Chicago
  • University of Chicago Comprehensive Cancer Center, Chicago
365 Days – 25 Years · Visoms lytims · Atnaujinta 2026-08-25 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Renkami dalyviai2 fazė
  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Amžius nuo 7 iki 25 · Visoms lytims · Atnaujinta 2026-08-19 · NCT05082519

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Renkami dalyviai1/2 fazė
  • Research Site, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT06137118

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

Renkami dalyviai1/2 fazė
  • Research Site, Chicago
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT07109219

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Renkami dalyviai2 fazė
  • University of Chicago Comprehensive Cancer Center, Chicago
Amžius nuo 18 iki 54 · Visoms lytims · Atnaujinta 2026-03-17 · NCT06918431

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

Renkami dalyviai1 fazė
  • University of Chicago Comprehensive Cancer Center, Chicago
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-04 · NCT03595917

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Renkami dalyviai1/2 fazė
  • University of Chicago, Chicago
Amžius nuo 15 iki 50 · Visoms lytims · Atnaujinta 2025-09-09 · NCT04150497

Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)

Renkami dalyviai
  • University of Chicago Medicine Comprehensive Cancer Center, Chicago
Amžius nuo 18 iki 50 · Visoms lytims · Atnaujinta 2025-06-19 · NCT06785324

Berkito limfoma tyrimai kituose miestuose

Kiti tyrimai Chicago

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.